Netherlands (NL)

Enhancement of springback prediction of AHSS parts by advanced friction modelling (2021) Durmaz U, Heibel S, Schweiker T, Merklein M, Berahmani S, Hol J, Naegele P Conference contribution ENETS consensus guidelines for synoptic reporting of radiology studies (2021) Dromain C, Vullierme MP, Hicks RJ, Prasad V, O'Toole D, De Herder WW, Pavel ME, et al. Journal article Too Blind to See the Elephant? Why Neuroscientists Ought to Be Interested in Tinnitus (2021) Knipper M, Mazurek B, Van Dijk P, Schulze H Journal article, Review article Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study (2021) Goessens L, Colombel JF, Outtier A, Ferrante M, Sabino J, Judge C, Saeidi R, et al. Journal article The EANM guideline for radiosynoviorthesis (2021) Kampen WU, Boddenberg-Paetzold B, Fischer M, Gabriel M, Klett R, Konijnenberg M, Kresnik E, et al. Journal article Distinct DNA Methylation Patterns of Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex (2021) Bongaarts A, Mijnsbergen C, Anink JJ, Jansen FE, Spliet WG, den Dunnen WF, Coras R, et al. Journal article Music, Computing, and Health: A Roadmap for the Current and Future Roles of Music Technology for Health Care and Well-Being (2021) Agres KR, Schaefer RS, Volk A, van Hooren S, Holzapfel A, Dalla Bella S, Müller M, et al. Journal article Physicians' Opinion and Practice With the Continuous Use of Sedatives in the Last Days of Life (2021) Heijltjes MT, Morita T, Mori M, Heckel M, Klein C, Stiel S, Miccinesi G, et al. Journal article The phase III NETTER-1 study of 177Lu-DOTATATE in patients with midgut neuroendocrine tumours: Further survival analyses (2021) Ruszniewski PB, Caplin ME, Kunz PL, Bodei L, Hendifar AE, Mittra E, Wolin EM, et al. Conference contribution PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2021) Girard N, Smit HJM, Sibille A, Mcdonald F, Mornex F, Garassino MCC, Filippi AR, et al. Conference contribution